methadone has been researched along with AIDS-Related Opportunistic Infections in 13 studies
Methadone: A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of MORPHINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3)
methadone : A racemate comprising equimolar amounts of dextromethadone and levomethadone. It is a opioid analgesic which is used as a painkiller and as a substitute for heroin in the treatment of heroin addiction.
6-(dimethylamino)-4,4-diphenylheptan-3-one : A ketone that is heptan-3-one substituted by a dimethylamino group at position 6 and two phenyl groups at position 4.
AIDS-Related Opportunistic Infections: Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include PNEUMOCYSTIS PNEUMONIA, Kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with Mycobacterium avium complex, Microsporidium, and Cytomegalovirus.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The diagnosis of pulmonary tuberculosis associated with Kaposi's sarcoma and immunosuppression caused by HIV was retained." | 5.46 | [TB/HIV co-infection associated with Kaposi's sarcoma under opioid substitution treatment using methadone: about a case]. ( Cisse Diallo, VMP; Deguenonvo, LF; Dièye, A; Diop Nyafouna, SA; Diop, M; Ka, D; Lakhe, NA; Massaly, A; Mbaye, KD; Ndiaye, I; Ndour, CT; Seydi, M; Thioub, D, 2017) |
| "Treatment with isoniazid was beneficial in HIV-infected, tuberculin-positive IDUs." | 5.32 | Effectiveness of isoniazid treatment for latent tuberculosis infection among human immunodeficiency virus (HIV)-infected and HIV-uninfected injection drug users in methadone programs. ( Amofa, J; Driver, CR; Fujiwara, PI; Gourevitch, MN; Highley, E; Kaye, K; Munsiff, SS; Rubino, MA; Scholten, JN; Seewald, R; Trim, C, 2003) |
| "The diagnosis of pulmonary tuberculosis associated with Kaposi's sarcoma and immunosuppression caused by HIV was retained." | 1.46 | [TB/HIV co-infection associated with Kaposi's sarcoma under opioid substitution treatment using methadone: about a case]. ( Cisse Diallo, VMP; Deguenonvo, LF; Dièye, A; Diop Nyafouna, SA; Diop, M; Ka, D; Lakhe, NA; Massaly, A; Mbaye, KD; Ndiaye, I; Ndour, CT; Seydi, M; Thioub, D, 2017) |
| "In a specialized heroin addiction treatment setting, patient compliance isjust as good as in other risk groups." | 1.33 | [HIV and drug users: current trends]. ( Golz, JH, 2005) |
| "Treatment with isoniazid was beneficial in HIV-infected, tuberculin-positive IDUs." | 1.32 | Effectiveness of isoniazid treatment for latent tuberculosis infection among human immunodeficiency virus (HIV)-infected and HIV-uninfected injection drug users in methadone programs. ( Amofa, J; Driver, CR; Fujiwara, PI; Gourevitch, MN; Highley, E; Kaye, K; Munsiff, SS; Rubino, MA; Scholten, JN; Seewald, R; Trim, C, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (46.15) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cisse Diallo, VMP | 1 |
| Deguenonvo, LF | 1 |
| Mbaye, KD | 1 |
| Ka, D | 1 |
| Lakhe, NA | 1 |
| Ndiaye, I | 1 |
| Thioub, D | 1 |
| Diop Nyafouna, SA | 1 |
| Massaly, A | 1 |
| Dièye, A | 1 |
| Diop, M | 1 |
| Ndour, CT | 1 |
| Seydi, M | 1 |
| Remy, AJ | 1 |
| Wenger, H | 1 |
| Bouchkira, H | 1 |
| Sabater, S | 1 |
| Usó, J | 1 |
| Moreno, R | 1 |
| Andrés, J | 1 |
| Scholten, JN | 1 |
| Driver, CR | 1 |
| Munsiff, SS | 1 |
| Kaye, K | 1 |
| Rubino, MA | 1 |
| Gourevitch, MN | 2 |
| Trim, C | 1 |
| Amofa, J | 1 |
| Seewald, R | 1 |
| Highley, E | 1 |
| Fujiwara, PI | 1 |
| Highleyman, L | 1 |
| Golz, JH | 1 |
| Swaminathan, S | 1 |
| Schoenbaum, EE | 1 |
| Klein, RS | 1 |
| Howard, AA | 1 |
| Lo, Y | 1 |
| Boissonnas, A | 1 |
| MacGregor, RR | 1 |
| Dunbar, D | 1 |
| Graziani, AL | 1 |
| Lee, HK | 1 |
| Bluestone, H | 1 |
| Frances, R | 1 |
| Brown, LS | 1 |
| Sawyer, RC | 1 |
| Li, R | 1 |
| Cobb, MN | 1 |
| Colborn, DC | 1 |
| Narang, PK | 1 |
| Antela, A | 1 |
| Casado, JL | 1 |
| González, MJ | 1 |
| Pérez, P | 1 |
| Pérez-Elías, MJ | 1 |
| Montilla, P | 1 |
| Buzón, L | 1 |
| Snyder, DC | 1 |
| Paz, EA | 1 |
| Mohle-Boetani, JC | 1 |
| Fallstad, R | 1 |
| Black, RL | 1 |
| Chin, DP | 1 |
1 review available for methadone and AIDS-Related Opportunistic Infections
| Article | Year |
|---|---|
[Nocardia brasiliensis cellulitis in an injection drug user].
Topics: AIDS-Related Opportunistic Infections; Arm; Cellulitis; Comorbidity; Humans; Injections, Intravenous | 2009 |
12 other studies available for methadone and AIDS-Related Opportunistic Infections
| Article | Year |
|---|---|
[TB/HIV co-infection associated with Kaposi's sarcoma under opioid substitution treatment using methadone: about a case].
Topics: AIDS-Related Opportunistic Infections; Coinfection; Female; Heroin Dependence; HIV Infections; Human | 2017 |
[Treatment of chronic hepatitis C in drug users: ethic, successful and useful].
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Buprenorphine; Comorbidity; Cooperative Beh | 2014 |
Effectiveness of isoniazid treatment for latent tuberculosis infection among human immunodeficiency virus (HIV)-infected and HIV-uninfected injection drug users in methadone programs.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Antitubercular Agents; Female; HIV; HIV Infectio | 2003 |
Drug interactions and anti-HIV therapy.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Anticholesteremic Agents; Contraceptives, Or | 2005 |
[HIV and drug users: current trends].
Topics: AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Comorbidity; Dose-Resp | 2005 |
Two-step tuberculin skin testing in drug users.
Topics: Adult; AIDS-Related Opportunistic Infections; Alcoholism; CD4 Lymphocyte Count; Comorbidity; Female; | 2007 |
[How to treat a patient with AIDS and drug dependence unwilling and/or unable to withdraw? Give substitution drugs at the hospital? Should substitution be continued after discharge? Is substitution a useful adjuvant to programs designed to prevent opportu
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Buprenorphine; Emergencie | 1994 |
Tuberculin reactions among attendees at a methadone clinic: relation to infection with the human immunodeficiency virus.
Topics: AIDS-Related Opportunistic Infections; Female; Humans; Incidence; Male; Methadone; Philadelphia; Sex | 1994 |
Screening and treatment of tuberculosis in a methadone maintenance treatment program.
Topics: Adult; AIDS-Related Opportunistic Infections; Comorbidity; Female; Heroin Dependence; Humans; Isonia | 1994 |
Lack of a pharmacologic interaction between rifabutin and methadone in HIV-infected former injecting drug users.
Topics: Adult; AIDS-Related Opportunistic Infections; Dose-Response Relationship, Drug; Drug Interactions; D | 1996 |
Influence of a methadone maintenance programme on the improved outcome of a cohort on injecting drug users with advanced HIV disease.
Topics: Adult; AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; Disease Progression; Female; HIV | 1997 |
Tuberculosis prevention in methadone maintenance clinics. Effectiveness and cost-effectiveness.
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Cost-Benefit Analysis; Drug The | 1999 |